EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.55 Billion EUR | -41.41% |
| 2022 | 11.19 Billion EUR | -1.88% |
| 2021 | 11.4 Billion EUR | 6.28% |
| 2020 | 10.73 Billion EUR | 26.55% |
| 2019 | 8.48 Billion EUR | 228.42% |
| 2018 | 2.58 Billion EUR | 54.3% |
| 2017 | 1.67 Billion EUR | 22.73% |
| 2016 | 1.36 Billion EUR | -28.4% |
| 2015 | 1.9 Billion EUR | 25.25% |
| 2014 | 1.52 Billion EUR | 150.58% |
| 2013 | 607 Million EUR | 15.35% |
| 2012 | 526.23 Million EUR | 70.22% |
| 2011 | 309.15 Million EUR | 8.26% |
| 2010 | 285.55 Million EUR | 1.18% |
| 2009 | 282.22 Million EUR | -35.51% |
| 2008 | 437.61 Million EUR | 0.47% |
| 2007 | 435.58 Million EUR | 65.62% |
| 2006 | 262.99 Million EUR | -41.41% |
| 2005 | 448.84 Million EUR | -24.65% |
| 2004 | 595.7 Million EUR | -0.41% |
| 2003 | 598.18 Million EUR | 70.66% |
| 2002 | 350.51 Million EUR | -0.58% |
| 2001 | 352.54 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 7.72 Billion EUR | -22.72% |
| 2024 Q2 | 5.06 Billion EUR | 0.0% |
| 2023 Q2 | 8.89 Billion EUR | 0.0% |
| 2023 Q1 | 8.89 Billion EUR | -20.5% |
| 2023 Q4 | 6.55 Billion EUR | -26.78% |
| 2023 Q3 | 8.95 Billion EUR | 0.66% |
| 2023 FY | 6.55 Billion EUR | -41.41% |
| 2022 Q3 | 10.19 Billion EUR | -0.54% |
| 2022 Q4 | 11.19 Billion EUR | 9.81% |
| 2022 Q1 | 10.24 Billion EUR | -10.17% |
| 2022 FY | 11.19 Billion EUR | -1.88% |
| 2022 Q2 | 10.24 Billion EUR | 0.0% |
| 2021 FY | 11.4 Billion EUR | 6.28% |
| 2021 Q1 | 10.27 Billion EUR | -4.31% |
| 2021 Q4 | 11.4 Billion EUR | 2.39% |
| 2021 Q2 | 10.52 Billion EUR | 2.47% |
| 2021 Q3 | 11.14 Billion EUR | 5.86% |
| 2020 FY | 10.73 Billion EUR | 26.55% |
| 2020 Q3 | 10.73 Billion EUR | -1.93% |
| 2020 Q1 | 10.94 Billion EUR | 29.03% |
| 2020 Q4 | 10.73 Billion EUR | 0.0% |
| 2020 Q2 | 10.94 Billion EUR | 0.0% |
| 2019 Q1 | 4 Billion EUR | 54.97% |
| 2019 FY | 8.48 Billion EUR | 228.42% |
| 2019 Q3 | 8.48 Billion EUR | 111.92% |
| 2019 Q4 | 8.48 Billion EUR | 0.0% |
| 2019 Q2 | 4 Billion EUR | 0.0% |
| 2018 Q2 | 1.6 Billion EUR | 0.0% |
| 2018 FY | 2.58 Billion EUR | 54.3% |
| 2018 Q4 | 2.58 Billion EUR | -36.14% |
| 2018 Q3 | 4.04 Billion EUR | 152.81% |
| 2018 Q1 | 1.6 Billion EUR | -4.42% |
| 2017 Q4 | 1.67 Billion EUR | 0.18% |
| 2017 Q3 | 1.67 Billion EUR | -9.28% |
| 2017 Q2 | 1.84 Billion EUR | 0.0% |
| 2017 Q1 | 1.84 Billion EUR | 35.04% |
| 2017 FY | 1.67 Billion EUR | 22.73% |
| 2016 Q2 | 1.65 Billion EUR | 0.0% |
| 2016 FY | 1.36 Billion EUR | -28.4% |
| 2016 Q1 | 1.65 Billion EUR | -12.91% |
| 2016 Q3 | 1.36 Billion EUR | -17.78% |
| 2016 Q4 | 1.36 Billion EUR | 0.0% |
| 2015 Q3 | 1.9 Billion EUR | 20.27% |
| 2015 FY | 1.9 Billion EUR | 25.25% |
| 2015 Q2 | 1.58 Billion EUR | 0.0% |
| 2015 Q4 | 1.9 Billion EUR | 0.0% |
| 2015 Q1 | 1.58 Billion EUR | 4.14% |
| 2014 Q2 | 1.75 Billion EUR | 0.0% |
| 2014 FY | 1.52 Billion EUR | 150.58% |
| 2014 Q3 | 1.52 Billion EUR | -13.38% |
| 2014 Q4 | 1.52 Billion EUR | 0.0% |
| 2014 Q1 | 1.75 Billion EUR | 189.29% |
| 2013 Q1 | 532.3 Million EUR | 1.15% |
| 2013 Q4 | 607 Million EUR | 0.0% |
| 2013 Q3 | 607 Million EUR | 14.03% |
| 2013 Q2 | 532.3 Million EUR | 0.0% |
| 2013 FY | 607 Million EUR | 15.35% |
| 2012 Q4 | 526.23 Million EUR | 0.0% |
| 2012 Q2 | 538.96 Million EUR | 0.0% |
| 2012 FY | 526.23 Million EUR | 70.22% |
| 2011 FY | 309.15 Million EUR | 8.26% |
| 2011 Q2 | 282.31 Million EUR | 0.0% |
| 2011 Q4 | 309.15 Million EUR | 0.0% |
| 2010 Q2 | 306.55 Million EUR | 0.0% |
| 2010 FY | 285.55 Million EUR | 1.18% |
| 2010 Q4 | 285.55 Million EUR | 0.0% |
| 2009 Q4 | 282.22 Million EUR | 0.0% |
| 2009 FY | 282.22 Million EUR | -35.51% |
| 2008 FY | 437.61 Million EUR | 0.47% |
| 2007 FY | 435.58 Million EUR | 65.62% |
| 2006 FY | 262.99 Million EUR | -41.41% |
| 2005 FY | 448.84 Million EUR | -24.65% |
| 2004 FY | 595.7 Million EUR | -0.41% |
| 2003 FY | 598.18 Million EUR | 70.66% |
| 2002 FY | 350.51 Million EUR | -0.58% |
| 2001 FY | 352.54 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -829.989% |
| Ansell Limited | 706.6 Million USD | -828.248% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -29166.143% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -1049340.0% |
| ConvaTec Group Plc | 1.22 Billion USD | -435.355% |
| ConvaTec Group Plc | 1.22 Billion USD | -434.599% |
| Encision Inc. | 67.33 Thousand USD | -9740603.338% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -1713161.78% |
| LifePoint, Inc. | 151.73 Thousand USD | -4322596.297% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -133375.783% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -1066404.065% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -3644538.064% |
| SmileDirectClub, Inc. | 849.37 Million USD | -672.211% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -3011.777% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -13526679.27% |
| Vasamed, Inc. | 18.95 Thousand USD | -34612037.203% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -35515386.246% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -1679778.088% |